BREWER RICHARD B 4
4 · Nile Therapeutics, Inc. · Filed Apr 2, 2012
Insider Transaction Report
Form 4
BREWER RICHARD B
DirectorExecutive Chairman
Transactions
- Purchase
Common Stock
2012-03-30+125,000→ 125,000 total - Purchase
Warrant (Right to Buy)
2012-03-30+93,750→ 93,750 totalExercise: $0.50→ Common Stock (93,750 underlying)
Holdings
- 900,000
Stock Option (Right to Buy)
Exercise: $0.37Exp: 2020-07-26→ Common Stock (900,000 underlying) - 450,000
Stock Option (Right to Buy)
Exercise: $0.32From: 2010-07-21Exp: 2020-07-21→ Common Stock (450,000 underlying)
Footnotes (3)
- [F1]The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
- [F2]This option vests in eight equal quarterly installments beginning 9/30/2011.
- [F3]The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.